Esprit BTK Post-Approval Study
The Esprit BTK PAS is a prospective, single-arm, multi-center observational study to
assess the continued safety and effectiveness of the Esprit™ BTK Everolimus Eluting
Resorbable Scaffold System under commercial use, in patients with diseased infrapopliteal
lesions ...
Age: 18 years - 66+
Gender: All
Esprit BTK Post-Approval Study
The Esprit BTK PAS is a prospective, single-arm, multi-center observational study to
assess the continued safety and effectiveness of the Esprit™ BTK Everolimus Eluting
Resorbable Scaffold System under commercial use, in patients with diseased infrapopliteal
lesions ...
Age: 18 years - 66+
Gender: All
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
A prospective, single-arm, multi-center study designed to gather additional information on
the LimFlow System.
Age: 18 - 95 years
Gender: All
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
A prospective, single-arm, multi-center study designed to gather additional information
on the LimFlow System.
Age: 18 - 95 years
Gender: All